IVF INVO Fertility, Inc. - Common Stock

NASDAQ · Health Care · View on SEC EDGAR ↗
$1.19
Price · Aug 19, 2026
Fundamentals as of Aug 14, 2026

IVF Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$1.19
Market Cap
P/E (TTM)
-0.0
EPS (TTM)
$-214.64
Revenue (TTM)
$7M
Div Yield
ROE
Debt/Equity
52W Range
$0 – $5

IVF Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $7M
4-point trend, +732.1%
2022-12-31 2025-12-31
EPS $-214.64
4-point trend, -1094.4%
2022-12-31 2025-12-31
Free Cash Flow
2023-12-31 2023-12-31
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
IVF
Peer Median
P/E (TTM)
4-point trend, +100.0%
-0.0
27.5

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
IVF
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
IVF
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
IVF
Peer Median
Revenue YoY
4-point trend, +732.1%
4.7%
Revenue CAGR 3Y
4-point trend, +732.1%
102.6%
Revenue CAGR 5Y
4-point trend, +732.1%
45.8%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
IVF
Peer Median
EPS (Diluted)
4-point trend, -1094.4%
$-214.64

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
IVF
Peer Median

IVF Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 5 analysts
  • Strong Buy 1 20.0%
  • Buy 3 60.0%
  • Hold 1 20.0%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

1 analysts · 2026-08-19
Median target $20.00 +1587.8%
Mean target $20.00 +1587.8%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-719.3%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-3.38 $-1.26 -2.1%
Dec. 31, 2025 $-196.81 $-2.78 -194.0%
Sept. 30, 2025 $-0.77 $-0.04 -0.73%
Dec. 31, 2024 $-3104.40 $-424.20 -2680.2%
Sept. 30, 2023 $-0.70
June 30, 2023 $-3.06

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
IVF -0.0 4.7%
GCTK $4M 0.1 -399.4%
TNON
AEMD $3M -0.2 -134.5%
ABT $250.18B 33.7 5.7% 14.7% 13.1%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 18
Annual Income Statement data for IVF
Metric Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +41142.2% $7M $7M $3M $822.2K $4M $1M $1M $494.4K $282.1K $50.9K $11.7K $16.6K
Cost of Revenue 11-point trend, +291.4% $30.6K $12.2K $2M $286.9K $126.3K $79.0K $133.7K $90.4K $52.0K $15.1K $7.8K ·
Gross Profit 9-point trend, +5409.5% · · · $490.7K $4M $948.5K $1M $404.0K $230.2K $35.8K $3.9K $8.9K
R&D Expense 6-point trend, +4880.00 · $4.9K $165.9K $544.0K $216.4K $398.4K $0 · · · · ·
SG&A Expense 12-point trend, +355.2% $8M $8M $7M $10M $9M $6M $3M $3M $870.6K $2M $599.0K $2M
Operating Expenses 12-point trend, +733.3% $14M $13M $10M $11M $9M $6M $3M $3M $870.6K $2M $599.0K $2M
Operating Income 12-point trend, -330.6% $-7M $-7M $-7M $-11M $-5M $-6M $-2M $-3M $-640.4K $-2M $-595.1K $-2M
Interest Expense 11-point trend, +1935.5% · $1M $925.9K $59.4K $1M $3M $387.6K $442.0K $20.9K $13.8K $32.0K $51.9K
Interest Income 2-point trend, -51.4% · · · · · $4.2K $8.6K · · · · ·
Other Non-op 9-point trend, +2936.0% $2M $-972.0K $-1M $-263.2K $-1M $-3M $-379.0K $-442.0K $-61.7K · · ·
Pretax Income 12-point trend, -216.7% $-5M $-8M $-8M $-11M $-7M $-8M $-2M $-3M $-702.2K $-2M $-5M $-2M
Income Tax 12-point trend, -150371.00 $-150.4K $140.2K $27.8K $2.9K $4.8K $36 $433 $0 $0 $0 $0 $0
Net Income 12-point trend, -1246.2% $-23M $-9M $-8M $-11M $-7M $-8M $-2M $-3M $-702.2K $-2M $-5M $-2M
EPS (Basic) 12-point trend, -1073100.0% $-214.64 $-3782.65 $-67.37 $-17.97 $-0.63 $-1.52 $-0.45 $-0.02 $0.00 $-0.02 $-0.04 $-0.02
EPS (Diluted) 12-point trend, -1073100.0% $-214.64 $-3782.65 $-67.37 $-17.97 $-0.63 $-1.52 $-0.45 $-0.02 $0.00 $-0.02 $-0.04 $-0.02
Shares (Basic) 12-point trend, -99.9% 117,083 2,514 119,264 606,130 10,632,413 5,489,738 4,854,878 147,333,051 141,305,050 139,186,557 128,567,615 112,672,160
Shares (Diluted) 12-point trend, -99.9% 117,083 2,514 119,264 606,130 10,632,413 5,489,738 4,854,878 147,333,051 141,305,050 139,186,557 128,567,615 112,672,160
EBITDA 5-point trend, -1014.0% · · $-7M · · · $-2M · $-637.6K $-2M $-589.4K ·
Balance Sheet 25
Annual Balance Sheet data for IVF
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +11055.6% $2M $619.5K $232.4K $90.1K $6M $10M $1M $212.2K $25.8K $152.4K $492.0K $18.6K
Receivables 12-point trend, +67583.2% $217.3K $113.1K $140.6K $77.1K $50.5K $21.7K $7.6K $225.9K $86.7K $2.8K $1.3K $321
Inventory 12-point trend, +260.7% $225.3K $219.8K $264.5K $263.6K $287.8K $265.4K $101.4K $43.5K $58.9K $85.2K $65.4K $62.5K
Prepaid Expense 12-point trend, +241145.00 $241.1K $180.9K $622.3K $190.2K $282.8K $157.7K $195.9K $249.5K $63.0K $11.0K $0 $0
Current Assets 12-point trend, +3292.4% $3M $1M $1M $621.1K $6M $11M $2M $731.1K $234.4K $251.4K $558.8K $81.4K
PP&E (Net) 12-point trend, +386165.00 $386.2K $466.7K $826.4K $436.7K $501.4K $132.2K $93.1K $34.4K $15.7K $15.7K $0 $0
Accum. Depreciation 8-point trend, +1179.7% $459.6K $335.7K $233.6K $153.3K $78.2K $52.3K $42.1K $35.9K · · · ·
Goodwill Flat — no change across 3 periods $6M $6M $6M · · · · · · · · ·
Intangibles 11-point trend, +4872.6% $1M $3M $4M · $132.1K $95.0K $7.2K $11.8K $16.3K $19.1K $21.0K $26.6K
Other Non-current Assets 7-point trend, +923.0% · · · · · $272.6K $159.0K $11.8K $16.3K $19.1K $21.0K $26.6K
Total Assets 12-point trend, +18613.5% $20M $46M $19M $4M $10M $11M $2M $777.3K $266.4K $286.2K $579.8K $108.1K
Accounts Payable 12-point trend, +66.1% $2M $3M $2M $1M $443.4K $328.9K $371.5K $571.8K $960.7K $974.9K $1M $1M
Short-term Debt 5-point trend, +100000.00 · · · $100.0K · $157.6K $0 $131.7K $0 · · ·
Current Liabilities 12-point trend, +131.3% $10M $18M $8M $3M $1M $2M $2M $4M $5M $5M $4M $4M
Capital Leases 8-point trend, +1171075.00 $1M $1M $3M $1M $2M $58.6K $81.5K $0 · · · ·
Deferred Tax 6-point trend, +163115.00 · $163.1K · $1.9K $1.1K $469 $433 $0 · · · ·
Total Liabilities 12-point trend, +190.9% $13M $26M $18M $5M $3M $5M $6M $4M $5M $5M $4M $4M
Long-term Debt 2-point trend, -88.0% $892.5K $7M · · · · · · · · · ·
Total Debt · · · · · · $0 · · · · ·
Common Stock 12-point trend, -98.0% $239 $37 $20 $61 $1.2K $964 $489 $15.4K $14.2K $14.1K $13.7K $12.0K
Paid-in Capital 8-point trend, +612.0% · · · · $46M $38M $20M $19M $14M $13M $12M $6M
Retained Earnings 12-point trend, -741.4% $-91M $-67M $-58M $-50M $-39M $-32M $-24M $-22M $-19M $-18M $-16M $-11M
Stockholders' Equity 12-point trend, +265.7% $7M $13M $892.8K $-977.6K $7M $6M $-4M $-3M $-5M $-5M $-4M $-4M
Liabilities + Equity 12-point trend, +18613.5% $20M $46M $19M $4M $10M $11M $2M $777.3K $266.4K $286.2K $579.8K $108.1K
Shares Outstanding 12-point trend, -99.6% 477,366 3,111 207,711 608,611 11,929,147 9,639,268 4,884,879 4,821,641 142,132,374 140,596,646 137,085,646 119,732,270
Cash Flow 15
Annual Cash Flow data for IVF
Metric Trend 202520242023202220212020201920182017201620152014
D&A 12-point trend, +6332.1% $677.4K $919.6K $200.9K $77.3K $27.8K $11.9K $10.8K $5.2K $2.8K $1.9K $5.6K $10.5K
Stock-based Comp 6-point trend, +162920.00 $162.9K · · $2M $2M $1M $69.8K $0 · · · ·
Deferred Tax Flat — no change across 3 periods · · · · · · · · · $0 $0 $0
Amort. of Intangibles 7-point trend, +12042.0% $553.4K $817.5K $120.6K $1.8K $1.8K $1.8K $4.6K · · · · ·
Other Non-cash 5-point trend, -35.9% · · $3M · · · $3M · $518.1K $2M $5M ·
Operating Cash Flow 12-point trend, -36055.3% $-7M $-3M $-5M $-7M $-6M $-5M $1M $-653.0K $-181.3K $-323.9K $-151.6K $-19.4K
CapEx 11-point trend, +43412.00 $43.4K $183.7K $444.7K $10.8K $415.7K $49.3K $64.8K $19.4K $0 $15.7K $0 ·
Investing Cash Flow 11-point trend, -2745481.00 $-3M $363.9K $-2M $-81.2K $-2M $-187.3K $-114.7K $-19.4K $0 $-15.7K $0 ·
Stock Issued 12-point trend, +61678.0% $12M $165.1K $6M $289.8K $4M $11M $0 $47.0K $54.6K $0 $645.0K $20.0K
Net Stock Activity 5-point trend, +784.0% · · $6M · · · $0 · $54.6K $0 $645.0K ·
Financing Cash Flow 12-point trend, +55382.1% $11M $3M $7M $1M $4M $14M $-229.5K $858.9K $54.6K $0 $625.0K $20.0K
Net Change in Cash 11-point trend, +223012.9% $1M $509.0K $142.3K $-6M $-4M $9M · $186.5K $-126.6K $-339.6K $473.4K $599
Taxes Paid 3-point trend, -24.7% · · · $800 $3.3K $1.1K · · · · · ·
Free Cash Flow 4-point trend, -1431.1% · · $-5M · · · $1M · $-181.3K $-339.6K · ·
Levered FCF 4-point trend, -1634.1% · · $-6M · · · $926.6K · $-202.1K $-353.4K · ·
Profitability 8
Annual Profitability data for IVF
Metric Trend 202520242023202220212020201920182017201620152014
Gross Margin 4-point trend, +172.9% · · · · · · 90.6% · 81.6% 70.3% 33.2% ·
Operating Margin 5-point trend, +95.6% · · -224.0% · · · -120.8% · -227.0% -4146.1% -5090.9% ·
Net Margin 5-point trend, +99.4% · · -266.0% · · · -146.4% · -248.9% -4173.3% -42426.6% ·
Pretax Margin 5-point trend, +99.4% · · -265.1% · · · -146.4% · -248.9% -4173.3% -42426.6% ·
EBITDA Margin 5-point trend, +95.7% · · -217.4% · · · -120.1% · -226.0% -4142.4% -5042.7% ·
ROA 4-point trend, +86.8% · · · · · · -168.5% · -254.1% -490.6% -1273.3% ·
ROE 4-point trend, -54.0% · · · · · · 58.0% · 14.6% 50.7% 126.2% ·
ROIC 4-point trend, +204.0% · · · · · · 48.2% · 12.8% 45.7% 15.8% ·
Liquidity & Solvency 4
Annual Liquidity & Solvency data for IVF
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 4-point trend, +698.3% · · · · · · 1.0 · 0.0 0.1 0.1 ·
Quick Ratio 4-point trend, +629.4% · · · · · · 0.8 · 0.0 0.0 0.1 ·
Debt / Equity · · · · · · 0.0 · · · · ·
Interest Coverage 5-point trend, +60.7% · · -7.3 · · · -4.7 · -30.7 -152.5 -18.6 ·
Efficiency 3
Annual Efficiency data for IVF
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 4-point trend, +3735.7% · · · · · · 1.2 · 1.0 0.1 0.0 ·
Inventory Turnover 3-point trend, +862.0% · · · · · · 1.9 · 0.7 0.2 · ·
Receivables Turnover 4-point trend, +46.0% · · · · · · 12.7 · 6.3 24.6 8.7 ·
Per Share 5
Annual Per Share data for IVF
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share 4-point trend, +13.1% · · · · · · $-0.02 · $-0.04 $-0.03 $-0.03 ·
Revenue / Share 5-point trend, +1928800.0% · · $1.93 · · · $0.01 · $0.00 $0.00 $0.00 ·
Cash Flow / Share 5-point trend, -252941.7% · · $-3.04 · · · $0.01 · $-0.00 $-0.00 $-0.00 ·
Cash / Share 4-point trend, +119.4% · · · · · · $0.01 · $0.00 $0.00 $0.00 ·
EPS (TTM) 11-point trend, -536500.0% $-214.64 $-30.19 $-67.37 $-17.97 $-0.63 $-1.52 $-0.45 $-0.02 $0.00 $-0.02 $-0.04 ·
Growth Rates 3
Annual Growth Rates data for IVF
Metric Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -98.4% 4.7% 116.3% 267.4% -80.2% 301.1% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +139.8% 102.6% 16.2% 42.8% · · · · · · · · ·
Revenue CAGR 5Y 45.8% · · · · · · · · · · ·
Valuation (TTM) 5
Annual Valuation (TTM) data for IVF
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM 11-point trend, +58427.2% $7M $7M $3M $822.2K $4M $1M $1M $494.4K $282.1K $50.9K $11.7K ·
Net Income TTM 11-point trend, -370.3% $-23M $-9M $-8M $-11M $-7M $-8M $-2M $-3M $-702.2K $-2M $-5M ·
P/E 6-point trend, +100.0% -0.0 -1.0 -0.7 -17.0 -3805.7 -1425.8 · · · · · ·
P / Tangible Book 4-point trend, -99.5% 17.9 3.0 · · 3984.3 3698.6 · · · · · ·
Earnings Yield 6-point trend, -40720828.6% -28504.6% -103.5% -138.6% -5.9% -0.03% -0.07% · · · · · ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312024-03-312023-12-312023-09-30
Revenue $7M$7M$3M
Operating Margin % -224.0%
Net Income $-23M$-9M$-8M
Diluted EPS $-214.64$-3782.65$-67.37
Cash Flow
2025-12-312024-12-312024-03-312023-12-312023-09-30
Free Cash Flow $-5M

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 2 filers · $1 total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
0 (-1 vs prior Q) 1 (-8 vs prior Q) 0 (0 vs prior Q) 0 (0 vs prior Q) -13

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Westfuller Advisors, LLC $1 1 100.00% Shares
HUNTINGTON NATIONAL BANK $0 1 0.00% Shares

Company insiders 10 insiders · 3 officers · 9 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Steve Shum Chief Executive Officer Dec. 31, 2020 A 1,000,000 0 0 $0
Michael Jos. Campbell Chief Operating Officer Dec. 31, 2020 A 1,607,800 0 0 $0
Kevin Doody Medical Director Dec. 31, 2020 A 169,821 0 0 $0
Jeffrey Segal Director Dec. 31, 2020 A 9,975 0 0 $0
Barbara Ryan Director Dec. 31, 2020 A 12,465 0 0 $0
Matthew K Szot Director Dec. 31, 2020 A 14,451 0 0 $0
Trent D Davis Director Dec. 31, 2020 A 13,573 0 0 $0
Kathleen T Karloff Director Feb. 5, 2020 A 13,200,183 0 0 $0
Robert Joseph Bowdring Jr Director Oct. 29, 2019 J 11,715,942 0 0 $0
Claude Ranoux Dec. 11, 2017 S 26,233,122 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 2 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
SS. OR ×3 filings Aug. 8, 2017 Initial filing Passive investment SEC
Undisclosed reporting person June 19, 2017 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.